Clinical Trial Update: An Open Label, Canadian Phase IIIb Study With Ovidrel in Ovulation Induction (OI) and Assisted Reproductive Technique (ART)

View source ↗

Summary

An open-label Canadian Phase IIIb trial evaluating Ovidrel for ovulation induction and assisted reproductive technology has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Ovidrel (Choriogonadotropin alfa)

Snippet

Sponsor: EMD Serono | Conditions: Ovulation Induction, Infertility | Status: COMPLETED